SAN DIEGO, Dec. 8 /PRNewswire/ -- PROVERI, Inc. is pleased to announce that it has been selected as a winner of the annual New England Venture Summit Top Innovator award by youngStartup Ventures. The list of privately held companies recognizes those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.
As one of the winners, Waldemar Lernhardt, Ph.D., President and Chief Executive Officer of PROVERI, Inc., will present the company at the exclusive 2009 New England Venture Summit on December 8th at the Hilton in Boston Dedham, where a select group of 450 entrepreneurs, investors, and corporate developers will gather to be the first to meet this next wave of leading edge companies.
Dr. Lernhardt stated that "PROVERI, Inc. is excited and honored to be in this very elite group of youngStartup Ventures Top finalists. In addition, we look forward to the company exposure provided at the New England Venture Summit."
About PROVERI, Inc.:
PROVERI, Inc. is developing personalized prostate cancer diagnostic and prognostic tests for prostate cancer, which will provide both the patient and physician with critical diagnostic and prognostic information for informed treatment choices. PROVERI, Inc. technology will allow for "mining" of the entire human genome to identify those genes that likely determine patient outcome, allowing the physician and patient to rationally select surgery, other treatments, or develop a watchful management regimen for prostate cancer (www.provericorp.com).
Honoring the Best
To honor the youngStartup Ventures Top Innovator recipients, youngStartup Ventures has invited their CEOs and founders to present at the New England Venture Summit, a forum for the most exciting early stage and emerging growth companies, and to share their insights on the future of innovation, and the entrepreneurial journey. This intimate, invitation-only conference is the premier venue for today's promising startups.
SOURCE PROVERI, Inc.
|SOURCE PROVERI, Inc.|
Copyright©2009 PR Newswire.
All rights reserved